August 20, 2014 7:28 AM ET

Biotechnology

Company Overview of Verex Laboratories, Inc.

Company Overview

Verex Laboratories, Inc. engages in the business of developing and marketing non-prescription and prescription drug products utilizing constant release rate drug delivery systems. The company has been in early stage development of a sustained drug delivery system that has shown potential for oral administration of drugs of macromolecule size, particularly proteins, polypeptides, and polysaccharides, which have low or no bioavailability when given orally. Its Veraderm is a wound dressing, made from a proprietary formulation of polymers that, when applied superficially to an open wound, can enhance healing while diminishing the chances of infection. In addition, the company offers a treatment ...

PO Box 885

Fort Collins, CO 80522

United States

Phone:

303-799-4499

Key Executives for Verex Laboratories, Inc.

Chairman of the Board
Age: 62
President and Director
Age: 64
Treasurer
Age: 68
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cell>Point L.L.C. United States
Vitae Pharmaceuticals, Inc. United States
Phytera, Inc. United States
GeneCentric Diagnostics, Inc. United States
Bell Biosystems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Verex Laboratories, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.